New device aims to catch debris and prevent stroke during artery stenting

NCT ID NCT07277296

Not yet recruiting Disease control Sponsor: InspireMD Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called SwitchGuard NPS that is designed to catch loose debris and protect the brain during a procedure to open narrowed neck arteries. About 103 people with carotid artery stenosis who are at high risk for standard surgery will receive the device along with a stent. Researchers will track how many have a stroke, heart attack, or die within 30 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SwitchGuard™ NPS (a device that catches debris during stenting) used with the CGuard™ Prime 80 carotid stent
What this could lead to: If it works, this could offer a safer way to open blocked neck arteries and reduce the risk of stroke during the procedure.
What could go wrong: This is a small, early-stage study with no comparison group, so results may not apply to everyone. The device itself carries risks like stroke, heart attack, or death.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CAROTID ARTERY STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carotid stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CAROTID ARTERY STENOSIS

More trials for these conditions

Other studies related to the condition(s) this trial covers.